(Q43833692)

27 November 2017

Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer (English)

1 reference

27 November 2017

1 reference

1 reference

Wan Zhao

1

1 reference

27 November 2017

Lingmin Hu

2

1 reference

27 November 2017

Jiali Xu

3

1 reference

27 November 2017

Hongbing Shen

4

1 reference

27 November 2017

Zhibin Hu

5

1 reference

27 November 2017

Hongxia Ma

6

1 reference

27 November 2017

Yongqian Shu

7

1 reference

27 November 2017

Yongfeng Shao

8

1 reference

27 November 2017

Yongmei Yin

9

1 reference

27 November 2017

12 March 2013

1 reference

Cancer Chemotherapy and Pharmacology

27 November 2017

1 reference

27 November 2017

71

1 reference

27 November 2017

5

1 reference

27 November 2017

1287-1295

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-013-2127-8

27 November 2017

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

The impact of tobacco on lung health in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Time trends in cancer mortality in China: 1987-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Meta-analysis of single agents in the chemotherapy of NSCLC: what do we want to know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Biomarkers in cancer staging, prognosis and treatment selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

21 January 2018

DNA damage and repair

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Nucleotide excision repair- and p53-deficient mouse models in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

21 January 2018

Human DNA repair genes

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

DNA repair in neurons: so if they don't divide what's to repair?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

XRCC1 co-localizes and physically interacts with PCNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Quality control by DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

Genetic variation in the DNA repair genes is predictive of outcome in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2127-8

10.1007/S00280-013-2127-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference